Cell Point
CELLPOINT NSE
Cell Point
RetailNSE: CELLPOINT Speciality Retail
Key Fundamentals
SMESpeciality RetailRetailMarket Cap
₹27.93 Cr
Volatility
Moderate
P/E Ratio
498.3
EBITDA
₹10.23 Cr
Return on Equity
3.05%
Debt to Equity
1.03
Book Value
₹39.77
EPS
₹0.91
52W High
₹21.1
52W Low
₹11.7
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.38 times its book value
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 11.0% over past five years.
- Company has a low return on equity of 1.10% over last 3 years.
Growth Rate
Revenue Growth
12.76% higher than
3Y
Net Income Growth
-89.57% lower than
3Y
Cash Flow Change
90.39% higher than
3Y
ROE
29.79% higher than
3Y
ROCE
-8.1% higher than
3Y
EBITDA Margin (Avg.)
2.21% higher than
3Y
Quarterly Results
| Particulars | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 147 | 158 | 163 | 154 | 171 | 177 | 191 |
| Expenses | 140 | 138 | 153 | 159 | 149 | 168 | 173 | 185 |
| Operating Profit | 9 | 9 | 5 | 4 | 5 | 3 | 4 | 6 |
| OPM % | 6% | 6% | 2.9% | 2.5% | 3% | 1.6% | 2.4% | 3.1% |
| Other Income | 1 | 1 | 2 | 0 | 1 | 3 | 0 | 0 |
| Interest | 4 | 5 | 3 | 2 | 2 | 3 | 3 | 4 |
| Depreciation | 0 | 1 | 0 | 2 | 3 | 0 | 1 | 2 |
| PBT | 5 | 4 | 2 | 0 | 0 | 2 | 0 | 1 |
| Tax % | 28% | 37% | 28% | 100% | 28% | 18% | 26% | 119% |
| Net Profit | 4 | 3 | 2 | 0 | 0 | 2 | 0 | 0 |
| EPS in Rs | 34.28 | 2.07 | 0.9 | 0.01 | 0.12 | 1.09 | 0.1 | -0.07 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 270 | 219 | 260 | 286 | 310 | 309 | 368 |
| Expenses | 261 | 211 | 249 | 268 | 301 | 302 | 358 |
| Operating Profit | 9 | 8 | 11 | 18 | 9 | 7 | 10 |
| OPM % | 3.5% | 3.6% | 4.2% | 6% | 2.8% | 2.4% | 2.8% |
| Other Income | 1 | 1 | 1 | 1 | 2 | 4 | 1 |
| Interest | 6 | 6 | 8 | 9 | 6 | 5 | 6 |
| Depreciation | 2 | 1 | 1 | 1 | 2 | 3 | 3 |
| PBT | 2 | 1 | 2 | 10 | 3 | 3 | 1 |
| Tax % | 33% | 46% | 32% | 32% | 38% | 20% | 94% |
| Net Profit | 2 | 1 | 2 | 7 | 2 | 2 | 0 |
| EPS in Rs | 14.06 | 6.07 | 14.5 | 4.93 | 0.9 | 1.21 | 0.03 |
| Div. Payout % | 0% | 0% | 0% | 0% | 28% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 14 | 19 | 19 | 19 |
| Reserves | 10 | 11 | 12 | 6 | 53 | 56 | 56 |
| Borrowings | 29 | 39 | 52 | 56 | 49 | 45 | 77 |
| Other Liabilities | 16 | 15 | 18 | 19 | 13 | 19 | 18 |
| Total Liabilities | 56 | 65 | 83 | 95 | 134 | 138 | 169 |
| Fixed Assets | 19 | 19 | 19 | 18 | 33 | 37 | 60 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 36 | 46 | 64 | 76 | 101 | 101 | 109 |
| Total Assets | 56 | 65 | 83 | 95 | 134 | 138 | 169 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 1 | 2 | 0 | 6 | -7 | -1 | 1 |
| Investing | -1 | -1 | 0 | -3 | -31 | 2 | -28 |
| Financing | 1 | 0 | 5 | -1 | 39 | -7 | 26 |
| Net Cash Flow | 1 | 1 | 5 | 2 | 2 | -6 | -1 |
| Free Cash Flow | 0 | 1 | -1 | 6 | -24 | -6 | -25 |
| CFO/OP | 26 | 39 | 5 | 42 | -62 | -9 | 19 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 1 | 0 | 1 | 0 | 0 | 1 | 1 |
| Inventory Days | 31 | 50 | 63 | 70 | 75 | 86 | 78 |
| Days Payable | 19 | 19 | 21 | 18 | 12 | 19 | 16 |
| Cash Conversion Cycle | 13 | 31 | 42 | 53 | 63 | 68 | 63 |
| Working Capital Days | 7 | -2 | -10 | -8 | -2 | 12 | 17 |
| ROCE % | — | 16% | 18% | 26% | 9% | 5% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Cell Point insights
56 extracted metrics + investor summaries across FY20–FY26.
Documents
1
Press Release
11 Sep - Newspaper advertisement issued for 13th AGM, annual report 2025-26, record date and e-voting details. 11 Sep - Newspaper advertisement issued for 13th AGM, annual report 2025-26, record date and e-voting details.
2
General Updates
9 Sep - FY2025-26 annual report corrigendum adds Form AOC-2; AGM on 29 Sep 2026 includes director reappointments. 9 Sep - FY2025-26 annual report corrigendum adds Form AOC-2; AGM on 29 Sep 2026 includes director reappointments.
3
Corrigendum
8 Sep - Cell Point corrected AGM notice annexures for 29 Sep 2026 AGM; no changes to resolutions. 8 Sep - Cell Point corrected AGM notice annexures for 29 Sep 2026 AGM; no changes to resolutions.
4
Shareholders meeting
3 Sep - Cell Point India schedules 13th AGM on 29 September 2026; record date 22 September 2026. 3 Sep - Cell Point India schedules 13th AGM on 29 September 2026; record date 22 September 2026.
5
Updates
3 Sep - Cell Point appoints scrutinizer for 13th AGM on 29 September 2026; e-voting period disclosed. 3 Sep - Cell Point appoints scrutinizer for 13th AGM on 29 September 2026; e-voting period disclosed.
Frequently Asked Questions about Cell Point
What does Cell Point (India) Ltd do?
Incorporated in 2001, Cell Point (India)
Ltd trades in smartphones and other
consumer durable electronic goods[1]
Where is Cell Point (India) Ltd (CELLPOINT) listed?
Cell Point (India) Ltd trades as CELLPOINT on the NSE.
Which sector does Cell Point (India) Ltd belong to?
Cell Point (India) Ltd is classified under the Retail sector, in the Speciality Retail industry.
What is the market capitalisation of Cell Point (India) Ltd?
Cell Point (India) Ltd has a market capitalisation of ₹27.93 Cr, which places it in the Small Cap band.
What is the PE ratio of Cell Point (India) Ltd?
Cell Point (India) Ltd trades at a PE ratio of 498.30, on earnings per share of ₹0.91, against a book value of ₹39.77 per share.
What is the 52-week high and low of Cell Point (India) Ltd?
Over the last 52 weeks Cell Point (India) Ltd has traded between ₹11.7 and ₹21.1.
Does Cell Point (India) Ltd pay dividends?
Cell Point (India) Ltd has a dividend yield of 1.67%.
What is the Return on Equity (ROE) of Cell Point (India) Ltd?
Cell Point (India) Ltd reported a return on equity of 3.05%. Its debt-to-equity ratio is 1.03.
Company Information
Incorporated in 2001, Cell Point (India) Ltd trades in smartphones and other consumer durable electronic goods[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CELLPOINT.md for Cell Point (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.